We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Diagnosing Liver Cancer Using Genetically Modified Probiotic Bacteria

By LabMedica International staff writers
Posted on 07 Jun 2015
Print article
Image: A space-filling model of firefly luciferin. Color coding: yellow = sulfur; blue = nitrogen; black = carbon; red = oxygen; white = hydrogen (Photo courtesy of Wikimedia Commons).
Image: A space-filling model of firefly luciferin. Color coding: yellow = sulfur; blue = nitrogen; black = carbon; red = oxygen; white = hydrogen (Photo courtesy of Wikimedia Commons).
A genetically engineered variety of the probiotic bacterium Escherichia coli Nissle 1917 was used to generate a luminescent diagnostic biomarker that could be detected in the urine of rodents with liver tumors.

Investigators at the Massachusetts Institute of Technology (Cambridge, MA, USA) and the University of California, San Diego (USA) genetically engineered E. coli Nissle 1917 to carry the gene that encodes a lacZ reporter enzyme, which would normally cleave lactose into glucose and galactose. For the current study galactose linked-luciferin was provided as the substrate in test rodents, and the enzyme acted on this complex to produce free, luminescent luciferin, which was excreted and could be detected in the urine.

The investigators reported in the May 27, 2015, online edition of the journal Science Translational Medicine that E. coli Nissle 1917 robustly colonized tumor tissue in rodent models of liver metastasis after oral delivery but did not colonize healthy organs or fibrotic liver tissue. The microbial diagnostic generated a high-contrast urine signal through selective expansion in liver metastases (106-fold enrichment) and high expression of the lacZ reporter maintained by engineering a stable plasmid system. No deleterious health effects were detected in the mice more than 12 months after oral delivery.

The orally delivered bacteria did not accumulate in tumors all over the body, but did become established in nearly 90% of metastatic tumors in mice with colon cancer that had spread to the liver.

"We realized that if we gave a probiotic, we were not going to be able to get bacteria concentrations high enough to colonize the tumors all over the body, but we hypothesized that if we had tumors in the liver they would get the highest dose from an oral delivery," said senior author Dr. Sangeeta Bhatia, professor of health sciences, electrical engineering, and computer science, at the Massachusetts Institute of Technology. "There are interventions, like local surgery or local ablation, that physicians can perform if the spread of disease in the liver is confined, and because the liver can regenerate, these interventions are tolerated. New data are showing that those patients have a higher survival rate, so there is a particular need for detecting early metastasis in the liver."

Related Links:

Massachusetts Institute of Technology
University of California, San Diego


Gold Member
Hematology Analyzer
Swelab Lumi
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
PSA Test
Human Semen Rapid Test
New
Vitamin B12 Test
CHORUS CLIA VIT B12

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.